Yes, it would fit within the scope of Pillar 3, but I don't think that it's a likely area for collaboration, because:
* the new molecules search is too open-ended; lawyers couldn't cope with drawing up the collaboration agreement
* CoH is far better staffed and experienced than RAC in this kind of work.
- Forums
- ASX - By Stock
- RAC
- IGF2BP2 - Jianjun Chen's new mRNA target
RAC
race oncology ltd
Add to My Watchlist
1.75%
!
$1.17

IGF2BP2 - Jianjun Chen's new mRNA target, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.17 |
Change
0.020(1.75%) |
Mkt cap ! $202.4M |
Open | High | Low | Value | Volume |
$1.16 | $1.18 | $1.16 | $29.49K | 25.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2588 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 8005 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2588 | 1.160 |
1 | 1000 | 1.155 |
2 | 2659 | 1.150 |
2 | 1703 | 1.145 |
6 | 7421 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 8005 | 3 |
1.175 | 12613 | 2 |
1.180 | 6775 | 2 |
1.185 | 805 | 1 |
1.195 | 1855 | 2 |
Last trade - 12.30pm 18/07/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |